Novadaq Technologies Inc.  

(Public, NASDAQ:NVDQ)   Watch this stock  
Find more results for NVDQ
-0.25 (-2.06%)
Apr 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 11.11 - 12.82
52 week 10.35 - 18.24
Open 12.10
Vol / Avg. 0.00/385,592.00
Mkt cap 659.10M
P/E     -
Div/yield     -
EPS -0.44
Shares 55.57M
Beta 0.84
Inst. own     -
May 21, 2015
Novadaq Technologies Inc Annual Shareholders Meeting (Estimated) - 9:30AM EDT - Add to calendar
Apr 28, 2015
Q1 2015 Novadaq Technologies Inc Earnings Call - 4:30PM EDT - Add to calendar
Apr 28, 2015
Q1 2015 Novadaq Technologies Inc Earnings Release - 4:00PM EDT - Add to calendar
Mar 12, 2015
Novadaq Technologies Inc at Barclays Healthcare Conference - Webcast
Feb 25, 2015
Q4 2014 Novadaq Technologies Inc Earnings Call
Feb 24, 2015
Q4 2014 Novadaq Technologies Inc Earnings Release
Feb 24, 2015
Novadaq Technologies Inc at RBC Healthcare Conference
More events from DailyFinance »    


5090 Explorer Dr Suite 202
+1-905-6293822 (Phone)
+1-905-6290282 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Novadaq Technologies Inc. primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. The Company's imaging platform can be used to visualize blood vessels, nerves and the lymphatic system during surgical procedures. The Company�s SPY, SPY Elite, LUNA and PINPOINT Imaging Systems are based upon the Company�s core SPY fluorescence technology. The Company manufactures and markets Heart Laser System [TMR Laser System] for Transmyocardial Revascularization [TMR]. The Company′s SPY Imaging core technology platform provides clinically relevant anatomic and physiologic images of blood flow in vessels and micro-vessels. PINPOINT provides surgeons with better visualization of important information related to anatomic structures and tissue perfusion during complex minimally invasive procedures.

Officers and directors

Arun Menawat Ph.D. President, Chief Executive Officer, Director
Bio & Compensation  - Reuters
Roger Deck Chief Financial Officer
Bio & Compensation  - Reuters
Mary Kay Baggs Senior Vice President of Marketing
Bio & Compensation  - Reuters
Bill Andreopoulos Controller
Bio & Compensation  - Reuters
Anthony F. Griffiths Independent Non-Executive Chairman of the Board
Age: 84
Bio & Compensation  - Reuters
Patrice E. Merrin Director
Age: 66
Bio & Compensation  - Reuters
Robert S. White Director
Age: 52
Bio & Compensation  - Reuters
G. Steven Burrill Independent Director
Age: 69
Bio & Compensation  - Reuters
Aaron Davidson Independent Director
Age: 46
Bio & Compensation  - Reuters